ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0599

Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic

Ulrich Drott1, Axel Braner1, Thomas Kollewe2, Harald Burkhardt3 and Florian Meier1, 1Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt, Germany, 2J. W. Goethe-Universität Frankfurt, FB Medizin, Frankfurter Arbeitsstelle für Medizindidaktik, Frankfurt, Germany, Frankfurt, Germany, 3Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt am Main, Germany

Meeting: ACR Convergence 2020

Keywords: Access to care, clinical trial, COVID-19, Health Care, Health Services Research

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Health Services Research Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The Covid-19 pandemic holds multiple challenges for the healthcare system. Quick adoptions and adjustments are the mainstays during these times. Hygiene management and plans in a primary care center for Covid-19, especially for prone patients such as patients with inflammatory rheumatic diseases receiving immunosuppressive or immunomodulatory therapies, are difficult. Nonetheless, monitoring of these treatments must be ensured. As a result, implementation of telephone visits was sought and rapidly achieved for most of the outpatient consultations.

The aim of this retrospective analysis was to evaluate the opinion of the patients regarding telephone consultations as a substitute for regular outpatient visits during the COVID-19 pandemic.

Methods: Patients were pre-screened for applicability and availability of a telephone consultation. After four weeks of mixed outpatient clinics (physical visits and majorly telephone visits), we performed a survey to inform our current concept during the outbreak. Patients (n=104) were randomly selected assuring to pick visits throughout the consulting hours. A 14-item questionnaire was developed and applied (graduation from 1 [do not agree at all]) to 5 [fully agree]). Additionally, we noted changes in therapy.

Results: On average, patients were 54 years old and for the most part female (69.2%). In general, patients reported an high agreement for the telephone visit (median 5 for the first six items: questions were equally answered as in regular visits; symptoms were reported sufficiently, and readily; telephone visit adequate if no acute problems were present; time saving; nonetheless well looked after). The quality of the connection did not influence the consultation and many (median 4) would participate in future telephone visits. Patients highly agreed to implement telephone visits as an additional tool for outpatient clinics despite the pandemic (median 5), however patients were divided as to favour physical visits or telephone or video consultations. Dosage adjustments were made in 14.4%, change of therapy at least in 5.7% of cases.

Conclusion: The participation in a pre-screened telephone consultation as an additive tool in the outpatient care of patients with rheumatic disease showed a high level of acceptance. It remains a matter of ongoing health services research as to which extent telephone and/or video consultations should steadily be implemented in outpatient rheumatology clinics, even after the Covid-19 outbreak, with regard to the current deficits in rheumatologic care, especially in Germany.


Disclosure: U. Drott, None; A. Braner, None; T. Kollewe, None; H. Burkhardt, AbbVie, 2, 5, 8, Pfizer, 2, 5, 8, Roche, 2, 5, 8, Boehringer Ingelheim, 5, 8, Bristol Myer Scripps, 5, 8, Chugai, 5, 8, Eli Lilly, 5, 8, Janssen, 5, 8, Novartis, 5, 8, Sanofi, 5, 8, UCB, 5, 8; F. Meier, None.

To cite this abstract in AMA style:

Drott U, Braner A, Kollewe T, Burkhardt H, Meier F. Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-telephone-consultations-in-germany-as-an-additional-tool-in-outpatient-rheumatology-clinics-during-the-covid-19-pandemic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-telephone-consultations-in-germany-as-an-additional-tool-in-outpatient-rheumatology-clinics-during-the-covid-19-pandemic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology